Published in Pancreas on July 01, 1997
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
The relationship between diabetes and pancreatic cancer. Mol Cancer (2003) 1.72
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Gastroenterology (2012) 1.34
Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci (2006) 1.27
Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas (2013) 1.00
Diabetes mellitus: a risk factor for pancreatic cancer? Langenbecks Arch Surg (2004) 0.85
Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85
High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. J Surg Res (2014) 0.83
Retracted The early diagnosis of pancreatic cancer and diabetes: what's the relationship? J Gastrointest Oncol (2014) 0.82
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer. J Natl Compr Canc Netw (2014) 0.79
Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (1982) 4.06
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett (1983) 3.12
Su(z)12, a novel Drosophila Polycomb group gene that is conserved in vertebrates and plants. Development (2001) 3.06
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A (1982) 2.89
Two different areas within the primary motor cortex of man. Nature (1996) 2.71
Broad line emission from iron K- and L-shell transitions in the active galaxy 1H 0707-495. Nature (2009) 2.64
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature (1980) 2.31
Evaluation of "HemoCue," a new device for determining hemoglobin. Clin Chem (1986) 2.23
Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand (1982) 2.23
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A (1987) 2.13
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (1987) 2.09
Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci U S A (1982) 2.03
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Activation by attention of the human reticular formation and thalamic intralaminar nuclei. Science (1996) 1.94
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev (2000) 1.73
Long-term prognosis for diabetic patients with foot ulcers. J Intern Med (1993) 1.70
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. Proc Natl Acad Sci U S A (1981) 1.63
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg (1993) 1.62
Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci (1995) 1.58
Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg (1993) 1.57
Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta (1999) 1.56
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A (1978) 1.47
Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis. Pancreatology (2005) 1.43
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases. Ann Clin Biochem (1992) 1.42
Atomic-scale visualization of inertial dynamics. Science (2005) 1.42
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience (1984) 1.41
Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology (1988) 1.40
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Muscle and plasma carnitine levels and urinary carnitine excretion in multiply injured patients on total parenteral nutrition. Clin Nutr (1984) 1.38
Preliminary report: role of peptide YY in defence against diarrhoea. Lancet (1990) 1.37
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas (2000) 1.33
Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology (1986) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regul Pept (1983) 1.29
Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia (2008) 1.29
Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury. Neuroscience (1985) 1.27
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci (Lond) (1981) 1.23
Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res (1985) 1.22
Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1983) 1.22
Regulatory peptides in the mammalian respiratory tract. Endocrinology (1982) 1.21
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand (1981) 1.20
Gut hormone release after intestinal resection. Gut (1982) 1.18
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol (1997) 1.17
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
Analysis of subjective, objective and functional examination tests after anterior cruciate ligament reconstruction. A follow-up of 527 patients. Knee Surg Sports Traumatol Arthrosc (1999) 1.16
Peptidergic innervation of the human male genital tract. J Urol (1983) 1.16
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut (1985) 1.15
Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endocrinology (1991) 1.15
Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications (2000) 1.14
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology (1983) 1.14
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut (1985) 1.14
Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg (1985) 1.14
Excitation transfer in complexes of horse liver alcohol dehydrogenase. Arch Biochem Biophys (1971) 1.14
Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion (1984) 1.13
Clocking femtosecond X rays. Phys Rev Lett (2005) 1.13
Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes (1985) 1.12
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun (1999) 1.12
Laboratory and field evaluation of three desktop instruments for assay of cholesterol and triglyceride. Clin Chem (1987) 1.12
Conformational studies on the pancreatic polypeptide hormone family. Eur J Biochem (1984) 1.11
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. FEBS Lett (1980) 1.11
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia (1978) 1.10
On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol (2004) 1.10